Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid PK in Renal Impairment
NCT02087566Phase 1Completed
- Sponsor
- Damanhour University
- Start
- Oct 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of linezolid in Gram-positive bacterial infection (3 arms), sponsored by Damanhour University. Primary endpoint: Tolerability at 6 weeks. Started Oct 2013; status: completed.
02
Drugs
linezolid
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on NCT02087566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087566.